<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3628745/" ref="ordinalpos=2704&amp;ncbi_uid=4868918&amp;link_uid=PMC3628745" image-link="/pmc/articles/PMC3628745/figure/fig-2/" class="imagepopup">Figure 2.  From: A new 12-gene diagnostic biomarker signature of melanoma revealed by integrated microarray analysis. </a></div><br /><div class="p4l_captionBody">A new signaling network for melanoma. The signaling network is based on the complex interactions of the 12 signature genes (labeled in red) and the 4 melanoma driver genes (BRAF, cKit, NRAS, MITF) in 3 signaling pathways (MAPK, Ca2+ and WNT). Nine of these 12 genes (i.e., EGFR, FGFR2, FGFR3, IL8, PTPRF, CXCL13, TNC, COL11A1, and SHC4) closely interact with three driver genes (NRAS, BRAF, and MITF) in the MAPK signaling pathway: the remaining 3 genes include WNT4, PPP2R2C and CHP2, which also play important roles in WNT and Ca2+ signaling pathways.</div></div>